XXII

22nd Century Group

0.0921 USD
-0.0027
2.85%
At close Nov 15, 4:00 PM EST
Pre-market
0.0997
+0.0076
8.25%
1 day
-2.85%
5 days
-13.93%
1 month
-29.96%
3 months
-84.26%
6 months
-94.17%
Year to date
-96.80%
1 year
-98.38%
5 years
-99.97%
10 years
-99.98%
 

About: 22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Employees: 64

0
Funds holding %
of 6,704 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

412% more capital invested

Capital invested by funds: $143K [Q2] → $732K (+$589K) [Q3]

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

13.49% more ownership

Funds ownership: 2.32% [Q2] → 15.81% (+13.49%) [Q3]

6% more funds holding

Funds holding: 33 [Q2] → 35 (+2) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Research analyst outlook

We haven’t received any recent analyst ratings for XXII.

Financial journalist opinion

Based on 3 articles about XXII published over the past 30 days

Charts implemented using Lightweight Charts™